Top insider buys: Aug 31 – Sep 6, 2020

The largest open-market purchases company insiders reported on SEC Form 4 between Aug 31 – Sep 6, 2020.

Week 36, 2020

#CompanyWho boughtSharesValueSource
1GBDC

GOLUB CAPITAL BDC, Inc.

2 officers/directors

Cluster buy

Lawrence E. Golub, David Golub

243,990

$3.2M

SEC filings
2FBIO

Fortress Biotech, Inc.

2 officers/directors

Cluster buy

Malcolm Hoenlein, Lindsay A. Rosenwald Md.

69,167

$1.2M

SEC filings
3GBLI

Global Indemnity Group, LLC

Director

Saul A. Fox

891,166

$20.7M

SEC filings
4IMVT

Immunovant, Inc.

10% Owner

Roivant Sciences Ltd.

380,000

$12.5M

SEC filings
5ETTX

Entasis Therapeutics Holdings Inc.

10% Owner

Innoviva, Inc.

4,672,897

$12.5M

SEC filings
6CAR

AVIS BUDGET GROUP, INC.

Director

SRS Investment Management, LLC

339,549

$11.8M

SEC filings
7RGT

ROYCE GLOBAL VALUE TRUST, INC.

Insider

Charles M. Royce

499,351

$7.1M

SEC filings
8THM

INTERNATIONAL TOWER HILL MINES LTD

2 separate filers

PAULSON & CO. INC., Electrum Strategic Opportunities Fund II L.P.

3,379,611

$4.7M

SEC filings
9LIND

LINDBLAD EXPEDITIONS HOLDINGS, INC.

Director

Smith, Jr. Thomas S.

269,790

$2.9M

SEC filings
10SAFE

Safehold Inc.

10% Owner

ISTAR INC.

22,360

$1.2M

SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.